Gyre Therapeutics, Inc. GYRE Total costs & expenses

Total costs & expenses at other companies

Madrigal Pharmaceuticals, Inc.MDGL

$40.01M+341%

Rigel PharmaceuticalsRIGL

$46.93M+15.7%

Zevra Therapeutics, Inc.ZVRA

$21.05M-13.1%

LQD

Liquidia CorporationLQDA

$86.16M+85.9%

BridgeBio PharmaBBIO

$350.76M+43.3%

Ligand PharmaceuticalsLGND

$55.1M+40.6%

FAQ

What is Gyre Therapeutics, Inc.'s total costs & expenses?

Gyre Therapeutics, Inc. (GYRE) reported total costs & expenses of $43.47M in Q2 2026.

How has Gyre Therapeutics, Inc.'s total costs & expenses changed year-over-year?

Gyre Therapeutics, Inc.'s total costs & expenses increased by 35.9% year-over-year, from $31.97M to $43.47M.

What is the long-term trend for Gyre Therapeutics, Inc.'s total costs & expenses?

Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s total costs & expenses has grown at a 6.5% compound annual growth rate (CAGR), from $93.09M to $112.48M.

What does total costs & expenses mean?

This metric represents the aggregate sum of all operating and non-operating costs incurred by the company during a reporting period, including cost of goods sold, research and development, and administrative overhead. It serves as a primary indicator of the company's total burn rate and operational efficiency in managing its cost structure. Monitoring this figure helps investors assess how effectively the company scales its spending relative to its revenue growth.